Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

(2002) · The Lancet · doi:10.1016/s0140-6736(02)09327-3 · Cited by 6,992

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y., Hendriksen, S. M., Kusek, J. W., & Lente, F. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,726

Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204

ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery,* Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation

Hirsch, A. T., Haskal, Z. J., Hertzer, N. R., Bakal, C. W., Creager, M. A., Halperin, J. L., Hiratzka, L. F., Murphy, W. R. C., Olin, J. W., Puschett, J. B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174526 · Cited by 3,708

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638

COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS

Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Pedersen, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,098

Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care

Hirsch, A. T. (2001) · JAMA · doi:10.1001/jama.286.11.1317 · Cited by 2,835

Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality

Fowkes, F. G. R., Murray, G. D., Butcher, I., Heald, C. L., Lee, R. J., Chambless, L. E., Folsom, A. R., Hirsch, A. T., Dramaix, M., DeBacker, G., et al. (2008) · JAMA · doi:10.1001/jama.300.2.197 · Cited by 1,870

Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease

Tuomilehto, J., Vidgrén, G., Toivanen, L., Tuomilehto‐Wolf, E., Kohtamäki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M. J., & Koskela, P. U. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,691

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease

Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

(1994) · Europe PMC (PubMed Central) · Cited by 755

Aspirin for Prevention of Cardiovascular Events in a General Population Screened for a Low Ankle Brachial Index<subtitle>A Randomized Controlled Trial</subtitle>

Fowkes, F. G. R. (2010) · JAMA · doi:10.1001/jama.2010.221 · Cited by 624

Red Blood Cell Distribution Width and Mortality Risk in a Community-Based Prospective Cohort

Perlstein, T. S., Weuve, J., Pfeffer, M. A., & Beckman, J. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.55 · Cited by 539

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

(2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.054 · Cited by 418

Primary Prevention of Cardiovascular Events With Low-Dose Aspirin and Vitamin E in Type 2 Diabetic Patients

Sacco, M., Pellegrini, F., Roncaglioni, M. C., Avanzini, F., Tognoni, G., Nicolucci, A., & on behalf of the PPP Collaborative Group (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3264 · Cited by 380

Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease

Berger, J. S., Krantz, M. J., Kittelson, J. M., & Hiatt, W. R. (2009) · JAMA · doi:10.1001/jama.2009.623 · Cited by 363

Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease

Östergren, J. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.033 · Cited by 324

Mortality and Cardiovascular Risk Across the Ankle-Arm Index Spectrum

O’Hare, A. M., Katz, R., Shlipak, M. G., Cushman, M., & Newman, A. B. (2006) · Circulation · doi:10.1161/circulationaha.105.570903 · Cited by 307

Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Cacoub, P., Abola, M. T. B., Baumgärtner, I., Bhatt, D. L., Creager, M. A., Liau, C., Goto, S., Röther, J., Steg, P. G., & Hirsch, A. T. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.10.023 · Cited by 257

ROC analysis of noninvasive tests for peripheral arterial disease

Lijmer, J. G., Hunink, M. G. M., van den Dungen, J. J. A. M., Loonstra, J., & Smit, A. J. (1996) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(96)00036-1 · Cited by 241

Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

Howard, W. J. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79115-7 · Cited by 209

Serum Total Bilirubin Level and Prevalent Lower-Extremity Peripheral Arterial Disease

Perlstein, T. S., Pande, R. L., Beckman, J. A., & Creager, M. A. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153262 · Cited by 187

Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement

U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-7-200910060-00008 · Cited by 180

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease

Feringa, H. H. H., van Waning, V. H., Bax, J. J., Elhendy, A., Boersma, E. H., Schouten, O., Galal, W., Vidaković, R., Tangelder, M. J. D., & Poldermans, D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.074 · Cited by 172

Association of Insulin Resistance and Inflammation With Peripheral Arterial Disease

Pande, R. L., Perlstein, T. S., Beckman, J. A., & Creager, M. A. (2008) · Circulation · doi:10.1161/circulationaha.107.721878 · Cited by 84

Medication Underuse During Long-Term Follow-Up in Patients With Peripheral Arterial Disease

Hoeks, S. E., Reimer, W. J. M. S. O., van Gestel, Y. R. B. M., Schouten, O., Lenzen, M. J., Flu, W., van Kuijk, J., Latour, C. H. M., Bax, J. J., van Urk, H., et al. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.868505 · Cited by 69

Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

Fowkes, F. G. R., Rudan, D., Rudan, I., Aboyans, V., Denenberg, J. O., McDermott, M. M., Norman, P. E., Sampson, U. K., Williams, L. J., Mensah, G. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61249-0 · Cited by 3,508

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease

Gerhard-Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.007 · Cited by 1,941

Epidemiology of Peripheral Artery Disease

Criqui, M. H., & Aboyans, V. (2015) · Circulation Research · doi:10.1161/circresaha.116.303849 · Cited by 1,785

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Gerhard‐Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000470 · Cited by 1,093

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Gerhard‐Herman, M. D., Gornik, H. L., Barrett, C., Barshes, N. R., Corriere, M. A., Drachman, D. E., Fleisher, L. A., Fowkes, F. G. R., Hamburg, N. M., Kinlay, S., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000471 · Cited by 1,048

Secondary Prevention and Mortality in Peripheral Artery Disease: National Health and Nutrition Examination Study, 1999 to 2004

Pande, R. T., Perlstein, T. S., & Beckman, J. A. (2012) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2012.01.023 · Cited by 23

Natural History of Peripheral Arterial Disease in the Era of Modern Cardiovascular Prevention

Kavaliūnaitė, E., Kristensen, K. L., Dahl, M., & Lindholt, J. S. (2021) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2021.10.007

Comparison of mortality in patients with coronary or peripheral artery disease following the first vascular intervention

Pereg, D., Elis, A., Neuman, Y., Mosseri, M., Segev, D., Granek-Catarivas, M., Lishner, M., & Hermoni, D. (2013) · Coronary Artery Disease · doi:10.1097/mca.0000000000000044 · Cited by 11

Ankle–Brachial Index Screening to Improve Health Outcomes: Where Is the Evidence?

(2015)

Cardioprotective Medication Is Associated With Improved Survival in Patients With Peripheral Arterial Disease

Feringa, H. H. H., van Waning, V. H., Bax, J. J., Elhendy, A., Boersma, E. H., Schouten, O., Galal, W., Vidaković, R., Tangelder, M. J. D., & Poldermans, D. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.09.074 · Cited by 172